Does Rallies show Form 4 insider transactions for VMD?

Yes. Rallies tracks VMD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is VMD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for VMD. It does not provide personalized investment advice.

VMD (Viemed Healthcare, Inc. Common Shares) Stock Analysis - Insider Trades

Viemed Healthcare, Inc. Common Shares (VMD) is a publicly traded Healthcare sector company. As of May 21, 2026, VMD trades at $9.70 with a market cap of $369.57M and a P/E ratio of 25.52. VMD moved +0.88% today. Year to date, VMD is +33.33%; over the trailing twelve months it is +42.35%. Its 52-week range spans $5.93 to $10.18. Rallies surfaces VMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading VMD stock inside the company?

Recent VMD insider activity includes Moore Michael sold 65.00K, Moore Michael sold 40.23K, Moore Michael sold 31.57K, Cambre Jerome sold 1.58K, and Cambre Jerome sold 3.30K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

VMD Key Metrics

Key financial metrics for VMD
Metric	Value
Price	$9.70
Market Cap	$369.57M
P/E Ratio	25.52
EPS	$0.38
Dividend Yield	0.00%
52-Week High	$10.18
52-Week Low	$5.93
Volume	19
Avg Volume	0
Revenue (TTM)	$286.56M
Net Income	$15.38M
Gross Margin	57.58%

Recent VMD Insider Trades

Moore Michael sold 65.00K (~$570.05K) on Mar 20, 2026.
Moore Michael sold 40.23K (~$370.54K) on Mar 19, 2026.
Moore Michael sold 31.57K (~$297.39K) on Mar 18, 2026.
Cambre Jerome sold 1.58K (~$11.58K) on Aug 13, 2025.
Cambre Jerome sold 3.30K (~$24.16K) on Aug 13, 2025.

Latest VMD News

Viemed Healthcare FCF Jumps to $36.3M; Ventilator Revenue Drops to 46.9% — May 12, 2026
Viemed Reports 28% Q1 Revenue Gain to $75.4M, Narrows 2026 Guidance — May 5, 2026
Viemed Posts Record Q4 Revenue, Guides Flat Q1, Expands Lehan Payer Network — Mar 10, 2026
Viemed Hits Record $270M Revenue, Guides 2026 for $310–320M with $65–69M EBITDA — Mar 6, 2026
Viemed Launches 5% Buyback Program to Repurchase 1.93M Shares by March 2027 — Mar 4, 2026

VMD Analyst Consensus

VMD analyst coverage data. Average price target: $0.00.

Common questions about VMD

Who is trading VMD stock inside the company?: Recent VMD insider activity includes Moore Michael sold 65.00K, Moore Michael sold 40.23K, Moore Michael sold 31.57K, Cambre Jerome sold 1.58K, and Cambre Jerome sold 3.30K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for VMD?: Yes. Rallies tracks VMD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is VMD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for VMD. It does not provide personalized investment advice.